|
Bob Chein, PhD
|
Dr. Jung-ting Chien is now CEO and co-founder of Marigen Inc, a cross-border marketplace for nutrient supplements. Dr. Chien was project manager in genotyping operation (B2B, B2C) at Thermo Fisher as well as an advisor for ATGENOMIX Inc before funding Marigen. Dr. Chien has extensive knowledge of A.I., machine learning, bioinformatics, biotechnology and clinical diagnostic technology. Prior to current roles, Dr. Chien founded a sequencing service company in 2015, and this company provided online NGS data analyses. Dr. Chien then joined Bayer AG to develop a machine learning based biologics product screening method. This method discovered potential product candidates that moved into the R&D pipeline. Dr. Chien serves on the board of advisors for SlingHealth, a start-up incubator, and as a founding member and board member of Formosa Enterprise Institute and the Bay Area Taiwanese Biotechnology Association. Dr. Chien received his Ph.D. in computer science and M.S. in data science from Emory University and his B.S. in medical technology from China Medical University, Taiwan.
